Grifols SA Barcelona


By |


As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 79% of sales in 2017. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics grew to almost 20% of revenue in 2014 with the acquisition of Novartis' diagnostics unit.

Contact Information

Main Phone: +34 935710500
Address: Avinguda de la Generalitat, 152-158
Address 2: Parque empresarial Can Sant Joan
City / Town: Barcelona
Country: ESP
Postal Code: 08174

Issuer Information

Exchange: OTO
CEO: Raimon Grifols Roura / Víctor Grifols Deu
Employees: 18296
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 20.47 $ 0. (0.00%)
Last Price 20.47 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 20.47
Last Trade Volume 0 52 Wk Hi 24.40 52 Wk Low 19.35
Market Cap 14 bi Ex-Div Date Div Rate 0.46 Yield 2.2260
Shares 683,737,763.00 EPS (TTM) 1.24 PE Ratio 16.70 Exchange OTCPK